Halozyme Therapeutics, Inc (HALO) Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology

Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Other Release

Newsdesk: